Millennium Management’s Unity Biotechnology UBX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-10,479
| Closed | -$14.1K | – | 4478 |
|
2024
Q2 | $14.1K | Sell |
10,479
-27,233
| -72% | -$36.8K | ﹤0.01% | 3857 |
|
2024
Q1 | $61.8K | Buy |
37,712
+24,274
| +181% | +$39.8K | ﹤0.01% | 3877 |
|
2023
Q4 | $25.9K | Buy |
+13,438
| New | +$25.9K | ﹤0.01% | 3879 |
|
2023
Q1 | – | Sell |
-16,546
| Closed | -$45K | – | 4982 |
|
2022
Q4 | $45K | Sell |
16,546
-82,933
| -83% | -$226K | ﹤0.01% | 4472 |
|
2022
Q3 | $393K | Buy |
99,479
+66,367
| +200% | +$262K | ﹤0.01% | 4012 |
|
2022
Q2 | $187K | Sell |
33,112
-42,104
| -56% | -$238K | ﹤0.01% | 4481 |
|
2022
Q1 | $842K | Buy |
75,216
+20,025
| +36% | +$224K | ﹤0.01% | 3704 |
|
2021
Q4 | $806K | Buy |
55,191
+11,260
| +26% | +$164K | ﹤0.01% | 3655 |
|
2021
Q3 | $1.32M | Sell |
43,931
-16,673
| -28% | -$500K | ﹤0.01% | 3402 |
|
2021
Q2 | $2.81M | Buy |
+60,604
| New | +$2.81M | ﹤0.01% | 2782 |
|
2020
Q3 | – | Sell |
-53,205
| Closed | -$4.62M | – | 3905 |
|
2020
Q2 | $4.62M | Buy |
53,205
+50,128
| +1,629% | +$4.35M | 0.01% | 1463 |
|
2020
Q1 | $178K | Sell |
3,077
-36,857
| -92% | -$2.13M | ﹤0.01% | 2763 |
|
2019
Q4 | $2.88M | Buy |
39,934
+18,667
| +88% | +$1.35M | ﹤0.01% | 1918 |
|
2019
Q3 | $1.3M | Buy |
21,267
+18,496
| +667% | +$1.13M | ﹤0.01% | 2200 |
|
2019
Q2 | $263K | Sell |
2,771
-5,771
| -68% | -$548K | ﹤0.01% | 3078 |
|
2019
Q1 | $693K | Buy |
+8,542
| New | +$693K | ﹤0.01% | 2606 |
|
2018
Q4 | – | Sell |
-4,090
| Closed | -$666K | – | 3705 |
|
2018
Q3 | $666K | Buy |
+4,090
| New | +$666K | ﹤0.01% | 2731 |
|